Pharmaceutical formulation containing opioid agonist, opioid...

Details Pharmaceutical formulation containing opioid agonist, opioid... Pharmaceutical formulation containing opioid agonist, opioid...

2002-08-06

2010-11-30

Kishore, Gollamudi S (Department: 1612)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C424S464000, C424S468000

Reexamination Certificate

active

07842307

ABSTRACT:
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid.

REFERENCES:
patent: 3980766 (1976-09-01), Shaw et al.
patent: 4070494 (1978-01-01), Hoffmeister et al.
patent: 4385057 (1983-05-01), Bjork et al.
patent: 4582835 (1986-04-01), Lewis et al.
patent: 4769372 (1988-09-01), Kreek
patent: 5149538 (1992-09-01), Granger et al.
patent: 5376705 (1994-12-01), Leys et al.
patent: 5403868 (1995-04-01), Reid et al.
patent: 5679650 (1997-10-01), Fukunaga et al.
patent: 5762963 (1998-06-01), Byas-Smith
patent: 5891919 (1999-04-01), Blum et al.
patent: 6277398 (2001-08-01), Caruso
patent: 6323242 (2001-11-01), Mueller
patent: 6375957 (2002-04-01), Kaiko et al.
patent: 6440464 (2002-08-01), Hsia et al.
patent: 6627635 (2003-09-01), Palermo et al.
patent: 6696088 (2004-02-01), Oshlack et al.
patent: 6716449 (2004-04-01), Oshlack et al.
patent: 7141250 (2006-11-01), Oshlack et al.
patent: 7157103 (2007-01-01), Sackler
patent: 7332182 (2008-02-01), Sackler
patent: 7658939 (2010-02-01), Oshlack et al.
patent: 7682632 (2010-03-01), Oshlack et al.
patent: 7718192 (2010-05-01), Oshlack et al.
patent: 7727557 (2010-06-01), Sackler
patent: 2003/0004177 (2003-01-01), Kao et al.
patent: 2003/0026838 (2003-02-01), Farrell
patent: 2003/0059471 (2003-03-01), Compton et al.
patent: 2003/0064099 (2003-04-01), Oshlack et al.
patent: 2003/0068276 (2003-04-01), Hughes et al.
patent: 2003/0073714 (2003-04-01), Breder et al.
patent: 2003/0084122 (2003-05-01), Saito
patent: 2003/0157168 (2003-08-01), Breder et al.
patent: 2004/0126428 (2004-07-01), Hughes et al.
patent: 2004/0131552 (2004-07-01), Boehm
patent: 2004/0186121 (2004-09-01), Oshlack et al.
patent: 2004/0228802 (2004-11-01), Chang et al.
patent: 2004/0228924 (2004-11-01), Oshlack et al.
patent: 2005/0112087 (2005-05-01), Musso et al.
patent: 2005/0163717 (2005-07-01), Anderson et al.
patent: 2005/0181046 (2005-08-01), Oshlack et al.
patent: 2005/0214223 (2005-09-01), Bartholomaeus et al.
patent: 2006/0182801 (2006-08-01), Breder et al.
patent: 2007/0014732 (2007-01-01), Sackler
patent: 2010/0151014 (2010-06-01), Liang et al.
patent: 2010/0152221 (2010-06-01), Liang et al.
patent: 1293195 (2003-03-01), None
patent: 01236298 (1989-09-01), None
patent: WO 95/20947 (1995-08-01), None
patent: 99/32119 (1999-07-01), None
patent: WO 02/094254 (2002-11-01), None
patent: WO 03/015531 (2003-02-01), None
patent: WO 03/092676 (2003-11-01), None
patent: WO/2009/085778 (2009-07-01), None
Kao et al, Abuse-Resistant Opioid Dosage Form, File date: May 11, 2001, Pub. Date:Jan. 2, 2003, US 2003/0004177.
Interview Summary issued in connection with U.S. Appl. No. 10/667,676 on Feb. 12, 2010.
Suggestion for Interference filed in connection with U.S. Appl. No. 10/689,866 on May 11, 2010.
Executed Employment Agreement of Ben Oshlack, Sep. 5, 1980.
Executed Employment Agreement of J.David Haddox, Aug. 13, 1999.
Executed Employment Agreement of Curtis Wright, Oct. 7, 1998.
Executed Employment Agreement of Christopher D. Breder, Aug. 13, 1999.
Notice of Recordation of Assignment Document dated Jan. 28, 2003, for U.S. Appl. No. 10/214,413 (including copies of the assignment documents).
Notice of Recordation of Assignment Document dated Dec. 11, 2007, for U.S. Appl. No. 10/214,413 (including a copy of the assignment document).
Notice of Recordation of Assignment Document dated May 10, 2001, for U.S. Appl. No. 09/781,081 (including copies of the assignment documents).
Notice of Recordation of Assignment Document dated Aug. 21, 2004, for U.S. Appl. No. 09/781,081 (including a copy of the assignment document).
Notice of Recordation of Assignment Document dated May 11, 2009, for U.S. Appl. Nos. 10/689,866; 10/700,861; 10/700,893; 10/700,906; 10/701,041; and 09/781,081 (including a copy of the assignment document).
Opinion and Order, Civil Action No. 1:08CV00050, Jun. 22, 2010.

Affiliated with

Also associated with

Rating

Pharmaceutical formulation containing opioid agonist, opioid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation containing opioid agonist, opioid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation containing opioid agonist, opioid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4209697